Prognostic models in bipolar disorder: can the prediction of the long-term clinical course rely on the integration of clinical and molecular data?

Biomark Med. 2014;8(3):371-4. doi: 10.2217/bmm.13.153.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antimanic Agents / therapeutic use
  • Biomarkers / metabolism
  • Bipolar Disorder / diagnosis*
  • Bipolar Disorder / drug therapy
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / metabolism
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Lithium / therapeutic use
  • Prognosis

Substances

  • Antimanic Agents
  • Biomarkers
  • Lithium
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3